Attitudes on Psychedelics in a Sample of Croatian Mental Health Professionals: A Cross-Sectional National Survey Study

References

• Barnett, B. S., Y. Beaussant, F. King IV, and R. Doblin. 2022. Psychedelic knowledge and opinions in psychiatrists at two professional conferences: An exploratory survey. Journal of Psychoactive Drugs 54 (3):269–77. doi:10.1080/02791072.2021.1957183.
   PubMed Web of Science ®Google Scholar
• Barnett, B. S., W. O. Siu, and H. G. Pope Jr. 2018. A survey of American psychiatrists’ attitudes toward classic hallucinogens. Journal of Nervous & Mental Disease 206 (6):476–80. doi:10.1097/nmd.0000000000000828.
   PubMed Web of Science ®Google Scholar
• Bender, D., and D. J. Hellerstein. 2022. Assessing the risk-benefit profile of classical psychedelics: A clinical review of second-wave psychedelic research. Psychopharmacology 239 (6):1907–32. doi:10.1007/s00213-021-06049-6.
   PubMed Web of Science ®Google Scholar
• Benet-Martínez, V., and O. P. John. 1998. Los cinco grandes across cultures and ethnic groups: Multitrait-multimethod analyses of the big five in Spanish and English. Journal of Personality and Social Psychology 75 (3):729–50. doi:10.1037/0022-3514.75.3.729.
   PubMed Web of Science ®Google Scholar
• Breeksema, J. J., B. W. Kuin, J. Kamphuis, W. van den Brink, E. Vermetten, and R. A. Schoevers. 2022. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Journal of Psychopharmacology 36 (10):1100–17. doi:10.1177/02698811221116926.
   PubMed Web of Science ®Google Scholar
• Caprara, G., M. Vecchione, and S. H. Schwartz. 2009. Mediational role of values in linking personality traits to political orientation. Asian Journal of Social Psychology 12 (2):82–94. doi:10.1111/j.1467-839X.2009.01274.x.
   Web of Science ®Google Scholar
• Carhart-Harris, R., B. Giribaldi, R. Watts, M. Baker-Jones, A. Murphy-Beiner, R. Murphy, J. Martell, A. Blemings, D. Erritzoe, and D. J. Nutt. 2021. Trial of psilocybin versus escitalopram for depression. The New England Journal of Medicine 384 (15):1402–11. doi:10.1056/NEJMoa2032994.
   PubMed Web of Science ®Google Scholar
• Dash, G. F., N. G. Martin, and W. S. Slutske. 2023. Big five personality traits and illicit drug use: Specificity in trait–drug associations. Psychology of Addictive Behaviors 37 (2):318–30. doi:10.1037/adb0000793.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., G. Agin-Liebes, M. España, B. Pilecki, and J. Luoma. 2022. Attitudes and beliefs about the therapeutic use of psychedelic drugs among psychologists in the United States. Journal of Psychoactive Drugs 54 (4):309–18. doi:10.1080/02791072.2021.1971343.
   PubMed Web of Science ®Google Scholar
• European Federation of Psychologists’ Associations. n.d. Full members. Accessed October 30, 2023. https://www.efpa.eu/members/full-members.
   Google Scholar
• European Psychiatric Association. n.d. National societies - Croatian psychiatric association - European psychiatric association. Accessed October 30, 2023. https://www.europsy.net/npa-members/?id=38.
   Google Scholar
• Gill, H., B. Gill, D. Chen-Li, S. El-Halabi, N. B. Rodrigues, D. S. Cha, O. Lipsitz, Y. Lee, J. D. Rosenblat, A. Majeed, et al. 2020. The emerging role of psilocybin and MDMA in the treatment of mental illness. Expert Review of Neurotherapeutics 20 (12):1263–73. doi:10.1080/14737175.2020.1826931.
   PubMed Web of Science ®Google Scholar
• Ginati, Y. D., N. Madjar, J. Ben-Sheetrit, S. Lev-Ran, A. Weizman, and G. Shoval. 2022. A nationwide study comparing mental health professionals’ willingness to try hallucinogenic drugs in basic research or clinical practice. Journal of Psychoactive Drugs 54 (2):177–87. doi:10.1080/02791072.2021.1941444.
   PubMed Web of Science ®Google Scholar
• Government of the Republic of Croatia. n.d. Office for the suppression of drug abuse. Accessed February 3, 2024. https://drogeiovisnosti.gov.hr/djelokrug/ovisnosti-i-vezane-teme/droge-i-ovisnost/vrste-droga/halucinogeni/1012.
   Google Scholar
• Grover, C., L. Monds, and M. Montebello. 2023. A survey of Australian psychiatrists’ and psychiatry trainees’ knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders. Australasian Psychiatry 31 (3):329–35. doi:10.1177/10398562231155125.
   PubMed Web of Science ®Google Scholar
• Gukasyan, N., R. R. Griffiths, D. B. Yaden, D. G. Antoine II, and S. M. Nayak. 2023. Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use. Journal of Psychopharmacology 37 (7):707–16. doi:10.1177/02698811231179910.
   PubMed Web of Science ®Google Scholar
• Hearn, B. G., M. D. Brubaker, and G. Richardson. 2022. Counselors’ attitudes toward psychedelics and their use in therapy. Journal of Counseling & Development 100 (4):364–73. doi:10.1002/jcad.12429.
   Web of Science ®Google Scholar
• Hovmand, O. R., E. D. Poulsen, S. Arnfred, and O. J. Storebø. 2023. Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review. Journal of Psychopharmacology 37 (7):649–59. doi:10.1177/02698811231180276.
   PubMed Web of Science ®Google Scholar
• Hu, L.-T., and P. M. Bentler. 1999. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal 6 (1):1–55. doi:10.1080/10705519909540118.
   Web of Science ®Google Scholar
• IsHak, W. W., P. Garcia, R. Pearl, J. Dang, C. William, J. Totlani, and I. Danovitch. 2023. The impact of psilocybin on patients experiencing psychiatric symptoms: A systematic review of randomized clinical trials. Innovations in Clinical Neuroscience 20 (4–6):39–48.
   PubMedGoogle Scholar
• Kardum, I., A. Gračanin, and J. Hudek-Knežević. 2006. Odnos crta ličnosti i stilova privrženosti s različitim aspektima seksualnosti kod žena i muškaraca. Psihologijske teme 15 (1):101–28.
   Google Scholar
• Kisely, S. 2023. The down-scheduling of MDMA and psilocybin(e): Too fast and too soon. Australian & New Zealand Journal of Psychiatry 57 (7):933–34. doi:10.1177/00048674231174171.
   PubMed Web of Science ®Google Scholar
• Kisely, S., M. Connor, A. A. Somogyi, and D. Siskind. 2023. A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders. Australian & New Zealand Journal of Psychiatry 57 (3):362–78. doi:10.1177/00048674221083868.
   PubMed Web of Science ®Google Scholar
• Ko, K., E. I. Kopra, A. J. Cleare, and J. J. Rucker. 2023. Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders 322:194–204. doi:10.1016/j.jad.2022.09.168.
   PubMed Web of Science ®Google Scholar
• Kuntsche, E., R. Knibbe, G. Gmel, and R. Engels. 2006. Who drinks and why? A review of socio-demographic, personality, and contextual issues behind the drinking motives in young people. Addictive Behaviors 31 (10):1844–57. doi:10.1016/j.addbeh.2005.12.028.
   PubMed Web of Science ®Google Scholar
• Luoma, J. B., B. Pilecki, A. K. Davis, and S. M. Smith. 2022. Predictors of attitudes toward psychedelics among psychologists in the USA. Drugs: Education, Prevention & Policy 30 (6):543–49. doi:10.1080/09687637.2022.2117022.
   Web of Science ®Google Scholar
• MacQuarrie, A. L., and C. Brunelle. 2022. Emerging attitudes regarding decriminalization: Predictors of pro-drug decriminalization attitudes in Canada. Journal of Drug Issues 52 (1):114–27. doi:10.1177/00220426211050030.
   Web of Science ®Google Scholar
• Malhi, G. S., C. M. Coulston, G. B. Parker, E. Cashman, G. Walter, L. A. Lampe, and U. Vollmer-Conna. 2011. Who picks psychiatry? Perceptions, preferences and personality of medical students. Australian & New Zealand Journal of Psychiatry 45 (10):861–70. doi:10.3109/00048674.2011.604301.
   PubMed Web of Science ®Google Scholar
• Marrs, H., M. R. Barb, and J. C. Ruggiero. 2007. Self-reported influences on psychology major choice and personality. Individual Differences Research 5 (4):289–99.
   Google Scholar
• Meir, P., L. Taylor, J. C. Soares, and T. D. Meyer. 2023. Psychotherapists’ openness to engage their patients in psilocybin-assisted therapy for mental health treatment. Journal of Affective Disorders 323:748–54. doi:10.1016/j.jad.2022.12.050.
   PubMed Web of Science ®Google Scholar
• Mühlig-Versen, A., C. E. Bowen, and U. M. Staudinger. 2012. Personality plasticity in later adulthood: Contextual and personal resources are needed to increase openness to new experiences. Psychology and Aging 27 (4):855–66. doi:10.1037/a0029357.
   PubMed Web of Science ®Google Scholar
• Nayak, S. M., M. K. Bradley, B. A. Kleykamp, E. C. Strain, R. H. Dworkin, and M. W. Johnson. 2023. Control conditions in randomized trials of psychedelics: An acttion systematic review. The Journal of Clinical Psychiatry 84 (3):22r14518. doi:10.4088/JCP.22r14518.
   PubMed Web of Science ®Google Scholar
• Naydenova, I., J. W. Lounsbury, J. J. Levy, and J. Y. Kim. 2012. Distinctive big five and narrow personality traits of psychology majors. Individual Differences Research 10 (3):129–40.
   Google Scholar
• Nour, M. M., L. Evans, and R. L. Carhart-Harris. 2017. Psychedelics, personality and political perspectives. Journal of Psychoactive Drugs 49 (3):182–91. doi:10.1080/02791072.2017.1312643.
   PubMed Web of Science ®Google Scholar
• Page, L. A., A. Rehman, H. Syed, K. Forcer, and G. Campbell. 2021. The readiness of psychiatrists to implement psychedelic-assisted psychotherapy. Frontiers in Psychiatry 12:743599. doi:10.3389/fpsyt.2021.743599.
   PubMed Web of Science ®Google Scholar
• Romeo, B., M. Hermand, A. Pétillion, L. Karila, and A. Benyamina. 2021. Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review. Journal of Psychiatric Research 137:273–82. doi:10.1016/j.jpsychires.2021.03.002.
   PubMed Web of Science ®Google Scholar
• Sellers, E. M., and M. K. Romach. 2023. Psychedelics: Science sabotaged by social media. Neuropharmacology, the Neuropharmacology of Social Behavior: From Bench to Bedside 227:109426. doi:10.1016/j.neuropharm.2023.109426.
   Google Scholar
• Sibley, C. G., D. Osborne, and J. Duckitt. 2012. Personality and political orientation: Meta‐analysis and test of a threat‐constraint model. Journal of Research in Personality 46 (6):664–77. doi:10.1016/j.jrp.2012.08.002.
   Web of Science ®Google Scholar
• Siegel, J. S., J. E. Daily, D. A. Perry, and G. E. Nicol. 2023. Psychedelic drug legislative reform and legalization in the US. JAMA Psychiatry 80 (1):77–83. doi:10.1001/jamapsychiatry.2022.4101.
   PubMed Web of Science ®Google Scholar
• Soto, C. J., and O. P. John. 2017. The next big five inventory (BFI-2): Developing and assessing a hierarchical model with 15 facets to enhance bandwidth, fidelity, and predictive power. Journal of Personality and Social Psychology 113 (1):117–43. doi:10.1037/pspp0000096.
   PubMed Web of Science ®Google Scholar
• Surbeck, W., R. Samuel, D. Spieler, E. Seifritz, G. Scantamburlo, M. N. Stienen, and F. Scholtes. 2020. Neurologists, neurosurgeons, and psychiatrists’ personality traits: A comparison. Acta Neurochirurgica 162 (3):461–68. doi:10.1007/s00701-020-04233-9.
   PubMed Web of Science ®Google Scholar
• Sutin, A. R., M. K. Evans, and A. B. Zonderman. 2013. Personality traits and illicit substances: The moderating role of poverty. Drug and Alcohol Dependence 131 (3):247–51. doi:10.1016/j.drugalcdep.2012.10.020.
   PubMed Web of Science ®Google Scholar
• Terracciano, A., C. E. Löckenhoff, R. M. Crum, O. J. Bienvenu, and P. T. Costa Jr. 2008. Five-factor model personality profiles of drug users. BMC Psychiatry 8 (1):22. doi:10.1186/1471-244X-8-22.
   PubMedGoogle Scholar
• Wells, A., M. Fernandes, and L. Reynolds. 2024. Perceptions and attitudes towards psychedelic-assisted psychotherapy among health professionals, patients, and the public: A systematic review. Journal of Psychedelic Studies 8 (1):43–62. doi:10.1556/2054.2023.00294.
   Google Scholar
• Zilberman, N., G. Yadid, Y. Efrati, Y. Neumark, and Y. Rassovsky. 2018. Personality profiles of substance and behavioral addictions. Addictive Behaviors 82:174–81. doi:10.1016/j.addbeh.2018.03.007.
   PubMed Web of Science ®Google Scholar
• Žuljević, M. F., I. Buljan, M. Leskur, M. Kaliterna, D. Hren, and D. Duplančić. 2022. Validation of a new instrument for assessing attitudes on psychedelics in the general population. Scientific Reports 12 (1):18225. doi:10.1038/s41598-022-23056-5.
   PubMed Web of Science ®Google Scholar